Swiss Pharma Hub Basel Frets Over Population Cap Threat
Roche and Novartis warn a proposed Swiss population cap threatens skilled talent access, risking R&D capabilities in Basel. Industry leaders argue this undermines Switzerland's status as a global phar
reuters · 2026-06-11 21:02 UTC